BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9344886)

  • 1. Pharmacokinetics and metabolism of dichloroacetate in the F344 rat after prior administration in drinking water.
    Gonzalez-Leon A; Schultz IR; Xu G; Bull RJ
    Toxicol Appl Pharmacol; 1997 Oct; 146(2):189-95. PubMed ID: 9344886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pretreatment with dichloroacetate or trichloroacetate on the metabolism of bromodichloroacetate.
    Austin EW; Bull RJ
    J Toxicol Environ Health; 1997 Nov; 52(4):367-83. PubMed ID: 9354181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and metabolism of [14C]dichloroacetate in male Sprague-Dawley rats. Identification of glycine conjugates, including hippurate, as urinary metabolites of dichloroacetate.
    James MO; Yan Z; Cornett R; Jayanti VM; Henderson GN; Davydova N; Katovich MJ; Pollock B; Stacpoole PW
    Drug Metab Dispos; 1998 Nov; 26(11):1134-43. PubMed ID: 9806957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition and recovery of rat hepatic glutathione S-transferase zeta and alteration of tyrosine metabolism following dichloroacetate exposure and withdrawal.
    Guo X; Dixit V; Liu H; Shroads AL; Henderson GN; James MO; Stacpoole PW
    Drug Metab Dispos; 2006 Jan; 34(1):36-42. PubMed ID: 16199472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione-dependent conversion to glyoxylate, a major pathway of dichloroacetate biotransformation in hepatic cytosol from humans and rats, is reduced in dichloroacetate-treated rats.
    James MO; Cornett R; Yan Z; Henderson GN; Stacpoole PW
    Drug Metab Dispos; 1997 Nov; 25(11):1223-7. PubMed ID: 9351896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue distribution, excretion, and urinary metabolites of dichloroacetic acid in the male Fischer 344 rat.
    Lin EL; Mattox JK; Daniel FB
    J Toxicol Environ Health; 1993 Jan; 38(1):19-32. PubMed ID: 8421320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions in the tumor-promoting activity of carbon tetrachloride, trichloroacetate, and dichloroacetate in the liver of male B6C3F1 mice.
    Bull RJ; Sasser LB; Lei XC
    Toxicology; 2004 Jul; 199(2-3):169-83. PubMed ID: 15147791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics and effects of dichloroacetic acid in rainbow trout.
    Fitzsimmons PN; Hoffman AD; Lien GJ; Hammermeister DE; Nichols JW
    Aquat Toxicol; 2009 Sep; 94(3):186-94. PubMed ID: 19656582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dichloroacetate and trichloroacetate promote clonal expansion of anchorage-independent hepatocytes in vivo and in vitro.
    Stauber AJ; Bull RJ; Thrall BD
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):287-94. PubMed ID: 9653059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dichloroacetate toxicokinetics and disruption of tyrosine catabolism in B6C3F1 mice: dose-response relationships and age as a modifying factor.
    Schultz IR; Merdink JL; Gonzalez-Leon A; Bull RJ
    Toxicology; 2002 May; 173(3):229-47. PubMed ID: 11960676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of short-term drinking water exposure to dichloroacetate on its pharmacokinetics and oral bioavailability in human volunteers: a stable isotope study.
    Schultz IR; Shangraw RE
    Toxicol Sci; 2006 Jul; 92(1):42-50. PubMed ID: 16611621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose pharmacokinetics and oral bioavailability of dichloroacetate in naive and GST-zeta-depleted rats.
    Saghir SA; Schultz IR
    Environ Health Perspect; 2002 Aug; 110(8):757-63. PubMed ID: 12153755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative evaluation of dichloroacetic acid kinetics in human--a physiologically based pharmacokinetic modeling investigation.
    Li T; Schultz I; Keys DA; Campbell JL; Fisher JW
    Toxicology; 2008 Mar; 245(1-2):35-48. PubMed ID: 18242812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dichloroacetic acid: metabolism in cytosol.
    Lipscomb JC; Mahle DA; Brashear WT; Barton HA
    Drug Metab Dispos; 1995 Nov; 23(11):1202-5. PubMed ID: 8591719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pre-treatment with dichloroacetic or trichloroacetic acid in drinking water on the pharmacokinetics of a subsequent challenge dose in B6C3F1 mice.
    Gonzalez-Leon A; Merdink JL; Bull RJ; Schultz IR
    Chem Biol Interact; 1999 Dec; 123(3):239-53. PubMed ID: 10654841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP technical report on toxicity studies of urethane in drinking water and urethane in 5% ethanol administered to F344/N rats and B6C3F1 mice.
    Chan PC
    Toxic Rep Ser; 1996 Mar; (52):1-91, A1-9, B1-9 passim. PubMed ID: 11803705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose kinetics and pyruvate dehydrogenase activity in septic rats treated with dichloroacetate.
    Lang CH; Bagby GJ; Blakesley HL; Spitzer JJ
    Circ Shock; 1987; 23(2):131-41. PubMed ID: 3315289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of glutathione S-transferase zeta and tyrosine metabolism by dichloroacetate: a potential unifying mechanism for its altered biotransformation and toxicity.
    Cornett R; James MO; Henderson GN; Cheung J; Shroads AL; Stacpoole PW
    Biochem Biophys Res Commun; 1999 Sep; 262(3):752-6. PubMed ID: 10471397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of bromodichloroacetate in B6C3F1 mice.
    Xu G; Stevens DK; Bull RJ
    Drug Metab Dispos; 1995 Dec; 23(12):1412-6. PubMed ID: 8689953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.